A patient receiving adjuvant chemoimmunotherapy for breast carcinoma developed urticaria secondary to cyclophosphamide, one of the drugs of the chemotherapy regimen. Chlorambucil, another alkylating agent, was substituted with no cross-sensitivity noted.
|Original language||English (US)|
|Number of pages||2|
|Journal||Archives of Internal Medicine|
|State||Published - Nov 1978|
ASJC Scopus subject areas
- Internal Medicine